Form 4: Organon & Co. Executive Susanne Fiedler Reports Stock Transactions

Chief Commercial Officer Susanne Fiedler reports acquisition of 3,594 shares of Organon & Co. common stock and disposition of 1,145 shares to cover tax obligations.

Summary

• On September 3, 2024, Susanne Fiedler, Chief Commercial Officer of Organon & Co., reported transactions involving the company's common stock.
• Fiedler acquired 3,594 shares of common stock related to performance share units granted on August 17, 2021, under the company's 2021 Incentive Stock Plan.
• The performance-vesting restrictions were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
• Fiedler also disposed of 1,145 shares of common stock at a price of $20.35 to satisfy tax obligations.
• Following these transactions, Fiedler beneficially owns 53,113 shares of Organon & Co. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and related to compensation and tax obligations. The vesting of performance shares suggests that performance goals were met, which is mildly positive.

Positives

• The release of performance-vesting restrictions indicates that performance goals were met, which is a positive signal.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored for insights into management's perspective on the company's value and prospects.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
• Companies like Pfizer (PFE) and Johnson & Johnson (JNJ), which operate in the same pharmaceutical industry, also have their executives and directors file Form 4s when they engage in transactions involving their company's stock.
• The reporting requirements and timelines are consistent across these companies, as dictated by SEC regulations.

Stakeholder Impact

• The stock transactions by a key executive could influence investor sentiment, although the impact is likely to be minimal given the routine nature of the transactions.
• The vesting of performance shares reflects positively on the company's performance, which benefits shareholders.

Key Dates